logo
Plus   Neg
Share
Email

Kohl's Slashes FY19 Adj. EPS Guidance - Quick Facts

While reporting financial results for the third quarter on Tuesday, retailer Kohl's Corp. (KSS) slashed its adjusted earnings guidance for the full-year 2019. For the third quarter, the company reported that comparable sales increased 0.4 percent.

For fiscal 2019, the company slashed its adjusted earnings guidance to a range of $4.75 to $4.95 from the prior guidance range of $5.15 to $5.45 per share.

The current guidance excludes $0.22 per share related to the extinguishment of debt and impairments, store closing and other costs recognized in the first nine months of 2019.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $5.19 per share for the year. Analysts' estimates typically exclude special items.

Last week, Kohl's Board of Directors declared a quarterly cash dividend on the Company's common stock of $0.67 per share, payable on December 24, 2019 to shareholders of record at the close of business on December 11, 2019.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
NBCUniversal unveiled Peacock, a free premium ad-supported streaming service with subscription tiers offering more than 600 movies and 400 series. Peacock will be available on April 15 for Comcast's Xfinity X1 and Flex customers and on July 15 for the rest of the country. NBC is offering Peacock... The number of Amazon Prime members in the U.S. is growing slowly, but steadily, a recent study has shown. According to the survey by the Consumer Intelligence Research Partners, LLC or CIRP, the number of Amazon Prime members in the U.S. is estimated to have risen to 112 million in December 2019 from just over 100 million in the same period of the prior year. Medical device manufacturer Cardinal Health will soon recall certain Level 3 surgical gowns or PreSource procedural packs that contain these gowns following warning that they may not be sterile, the U.S. Food and Drug Administration said in a statement. The health regulator said it is working with the company to find out the specific product lots that are impacted.
Follow RTT
>